353 related articles for article (PubMed ID: 26550783)
1. Cellular uptake and transcytosis of lipid-based nanoparticles across the intestinal barrier: Relevance for oral drug delivery.
Neves AR; Queiroz JF; Costa Lima SA; Figueiredo F; Fernandes R; Reis S
J Colloid Interface Sci; 2016 Feb; 463():258-65. PubMed ID: 26550783
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of transport of saquinavir-loaded nanostructured lipid carriers across the intestinal barrier.
Beloqui A; Solinís MÁ; Gascón AR; del Pozo-Rodríguez A; des Rieux A; Préat V
J Control Release; 2013 Mar; 166(2):115-23. PubMed ID: 23266764
[TBL] [Abstract][Full Text] [Related]
3. Self-Assembled Core-Shell-Type Lipid-Polymer Hybrid Nanoparticles: Intracellular Trafficking and Relevance for Oral Absorption.
Li Q; Xia D; Tao J; Shen A; He Y; Gan Y; Wang C
J Pharm Sci; 2017 Oct; 106(10):3120-3130. PubMed ID: 28559042
[TBL] [Abstract][Full Text] [Related]
4. Size-exclusive effect of nanostructured lipid carriers on oral drug delivery.
Li H; Chen M; Su Z; Sun M; Ping Q
Int J Pharm; 2016 Sep; 511(1):524-537. PubMed ID: 27452421
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of transport of polymeric and lipidic nanoparticles across the intestinal barrier.
Beloqui A; des Rieux A; Préat V
Adv Drug Deliv Rev; 2016 Nov; 106(Pt B):242-255. PubMed ID: 27117710
[TBL] [Abstract][Full Text] [Related]
6. Transport Mechanisms of Solid Lipid Nanoparticles across Caco-2 Cell Monolayers and their Related Cytotoxicology.
Chai GH; Xu Y; Chen SQ; Cheng B; Hu FQ; You J; Du YZ; Yuan H
ACS Appl Mater Interfaces; 2016 Mar; 8(9):5929-40. PubMed ID: 26860241
[TBL] [Abstract][Full Text] [Related]
7. The transport mechanisms of polymer nanoparticles in Caco-2 epithelial cells.
He B; Lin P; Jia Z; Du W; Qu W; Yuan L; Dai W; Zhang H; Wang X; Wang J; Zhang X; Zhang Q
Biomaterials; 2013 Aug; 34(25):6082-98. PubMed ID: 23694903
[TBL] [Abstract][Full Text] [Related]
8. [Construction of Oral Insulin-Loaded Solid Lipid Nanoparticles and Their Intestinal Epithelial Cell Transcytosis Study].
Zheng YX; He Q; Xu M; Huang Y
Sichuan Da Xue Xue Bao Yi Xue Ban; 2021 Jul; 52(4):570-576. PubMed ID: 34323033
[TBL] [Abstract][Full Text] [Related]
9. Polyester-Solid Lipid Mixed Nanoparticles with Improved Stability in Gastro-Intestinal Tract Facilitated Oral Delivery of Larotaxel.
Gou J; Feng S; Liang Y; Fang G; Zhang H; Yin T; Zhang Y; He H; Wang Y; Tang X
Mol Pharm; 2017 Nov; 14(11):3750-3761. PubMed ID: 28945434
[TBL] [Abstract][Full Text] [Related]
10. Lipid nanovehicles with adjustable surface properties for overcoming multiple barriers simultaneously in oral administration.
Wu L; Liu M; Shan W; Cui Y; Zhang Z; Huang Y
Int J Pharm; 2017 Mar; 520(1-2):216-227. PubMed ID: 28185960
[TBL] [Abstract][Full Text] [Related]
11. Improved transport and absorption through gastrointestinal tract by PEGylated solid lipid nanoparticles.
Yuan H; Chen CY; Chai GH; Du YZ; Hu FQ
Mol Pharm; 2013 May; 10(5):1865-73. PubMed ID: 23495754
[TBL] [Abstract][Full Text] [Related]
12. Apo E-Functionalization of Solid Lipid Nanoparticles Enhances Brain Drug Delivery: Uptake Mechanism and Transport Pathways.
Neves AR; Queiroz JF; Lima SAC; Reis S
Bioconjug Chem; 2017 Apr; 28(4):995-1004. PubMed ID: 28355061
[TBL] [Abstract][Full Text] [Related]
13. Lipid nanocarriers improve paclitaxel transport throughout human intestinal epithelial cells by using vesicle-mediated transcytosis.
Roger E; Lagarce F; Garcion E; Benoit JP
J Control Release; 2009 Dec; 140(2):174-81. PubMed ID: 19699246
[TBL] [Abstract][Full Text] [Related]
14. Transport mechanism of lipid covered saquinavir pure drug nanoparticles in intestinal epithelium.
Xia D; He Y; Li Q; Hu C; Huang W; Zhang Y; Wan F; Wang C; Gan Y
J Control Release; 2018 Jan; 269():159-170. PubMed ID: 29129657
[TBL] [Abstract][Full Text] [Related]
15. Cellular interactions of a lipid-based nanocarrier model with human keratinocytes: Unravelling transport mechanisms.
Silva E; Barreiros L; Segundo MA; Costa Lima SA; Reis S
Acta Biomater; 2017 Apr; 53():439-449. PubMed ID: 28119111
[TBL] [Abstract][Full Text] [Related]
16. In vitro intestinal co-culture cell model to evaluate intestinal absorption of edelfosine lipid nanoparticles.
Lasa-Saracíbar B; Guada M; Sebastián V; Blanco-Prieto MJ
Curr Top Med Chem; 2014; 14(9):1124-32. PubMed ID: 24678709
[TBL] [Abstract][Full Text] [Related]
17. Cellular internalization pathway and transcellular transport of pegylated polyester nanoparticles in Caco-2 cells.
Song Q; Wang X; Hu Q; Huang M; Yao L; Qi H; Qiu Y; Jiang X; Chen J; Chen H; Gao X
Int J Pharm; 2013 Mar; 445(1-2):58-68. PubMed ID: 23380624
[TBL] [Abstract][Full Text] [Related]
18. Cellular uptake and transport characteristics of chitosan modified nanoparticles in Caco-2 cell monolayers.
Dou T; Wang J; Han C; Shao X; Zhang J; Lu W
Int J Biol Macromol; 2019 Oct; 138():791-799. PubMed ID: 31356947
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of nanoparticle internalization and transport across an intestinal epithelial cell model: effect of size and surface charge.
Bannunah AM; Vllasaliu D; Lord J; Stolnik S
Mol Pharm; 2014 Dec; 11(12):4363-73. PubMed ID: 25327847
[TBL] [Abstract][Full Text] [Related]
20. Long-term stability, biocompatibility and oral delivery potential of risperidone-loaded solid lipid nanoparticles.
Silva AC; Kumar A; Wild W; Ferreira D; Santos D; Forbes B
Int J Pharm; 2012 Oct; 436(1-2):798-805. PubMed ID: 22867992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
